Area of research
Ophthalmology · Oncology
Research interest
Research interests include Medicine, Macular degeneration, Ranibizumab, Ophthalmology, Port (circuit theory), and Visual acuity.
Ocular Half-Life: What it Does and Does Not Mean for Intravitreal Anti-angiogenic Drug Durability
Archway Randomized Phase 3 Trial of the Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration
The Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration
Determination of Cellular Processing Rates for a Trastuzumab-Maytansinoid Antibody-Drug Conjugate (ADC) Highlights Key Parameters for ADC Design